Innovative Biologics and Biosimilars - Global and China Top Players Market Share and Ranking 2023
- Report Code : AMP2757520
- Published On: Oct, 2024
- Category : Healthcare & Pharma
- Pages : 161
-
According to Ample Market Research, the global market for Innovative Biologics and Biosimilars should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Innovative Biologics and Biosimilars market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Innovative Biologics and Biosimilars market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospital grew percent to account for percent of the total market sales, and Retail Pharmacy grew percent.
Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin, interferon, and monoclonal antibody (mAb) products.
This report studies and analyses global Innovative Biologics and Biosimilars status and future trends, to help determine the Innovative Biologics and Biosimilars market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Innovative Biologics and Biosimilars, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Innovative Biologics and Biosimilars market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)
(2) Global Innovative Biologics and Biosimilars by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(3) China Innovative Biologics and Biosimilars by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(4) Global Innovative Biologics and Biosimilars key consuming regions, consumption value and demand structure
(5) Innovative Biologics and Biosimilars industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
Biogen
Celltrion
Sobi
3SBIO
Changchun High Tech
Kanghong Pharma
Innovent Biologics
Gan&Lee
Tonghua Dongbao
United Laboratory
Market segment by Type, covers
Monoclonal Antibodies
Interferon
Insulin
Vaccines
Others
Market segment by Application, can be divided into
Hospital
Retail Pharmacy
Other
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Innovative Biologics and Biosimilars product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Innovative Biologics and Biosimilars market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 3: China Innovative Biologics and Biosimilars market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 4: Innovative Biologics and Biosimilars industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
-
With tables and figures helping analyze worldwide Innovative Biologics and Biosimilars Global and China Top Players market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Market Overview1.1 Innovative Biologics and Biosimilars Definition
1.2 Global Innovative Biologics and Biosimilars Market Size and Forecast
1.3 China Innovative Biologics and Biosimilars Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Innovative Biologics and Biosimilars Market Size: China VS Global Growth Rate, 2018-2029
1.6 Innovative Biologics and Biosimilars Market Dynamics
1.6.1 Innovative Biologics and Biosimilars Market Drivers
1.6.2 Innovative Biologics and Biosimilars Market Restraints
1.6.3 Innovative Biologics and Biosimilars Industry Trends
1.6.4 Innovative Biologics and Biosimilars Industry Policy
2 Global Leading Players and Market Share2.1 By Revenue of Innovative Biologics and Biosimilars, Global Market Share by Company, 2018-2023
2.2 Global Innovative Biologics and Biosimilars Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Innovative Biologics and Biosimilars Concentration Ratio
2.4 Global Innovative Biologics and Biosimilars Mergers & Acquisitions, Expansion Plans
2.5 Global Innovative Biologics and Biosimilars Major Companies Product Type
2.6 Head Office and Innovative Biologics and Biosimilars Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking3.1 By Revenue of Innovative Biologics and Biosimilars, China Market Share by Company, 2018-2023
3.2 China Innovative Biologics and Biosimilars Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis4.1 Innovative Biologics and Biosimilars Industry Chain
4.2 Innovative Biologics and Biosimilars Upstream Analysis
4.2.1 Innovative Biologics and Biosimilars Core Raw Materials
4.2.2 Main Manufacturers of Innovative Biologics and Biosimilars Core Raw Materials4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Innovative Biologics and Biosimilars Production Mode
4.6 Innovative Biologics and Biosimilars Procurement Model
4.7 Innovative Biologics and Biosimilars Industry Sales Model and Sales Channels
4.7.1 Innovative Biologics and Biosimilars Sales Model
4.7.2 Innovative Biologics and Biosimilars Typical Distributors
5 Sights by Type5.1 Innovative Biologics and Biosimilars Classification
5.1.1 Monoclonal Antibodies
5.1.2 Interferon
5.1.3 Insulin
5.1.4 Vaccines
5.1.5 Others5.2 By Type, Global Innovative Biologics and Biosimilars Consumption Value & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Innovative Biologics and Biosimilars Consumption Value, 2018-2029
6 Sights by Application6.1 Innovative Biologics and Biosimilars Segment by Application
6.1.1 Hospital
6.1.2 Retail Pharmacy
6.1.3 Other6.2 By Application, Global Innovative Biologics and Biosimilars Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Innovative Biologics and Biosimilars Consumption Value, 2018-2029
7 Sales Sights by Region7.1 By Region, Global Innovative Biologics and Biosimilars Consumption Value, 2018 VS 2022 VS 2029
7.2 By Region, Global Innovative Biologics and Biosimilars Consumption Value, 2018-2029
7.3 North America
7.3.1 North America Innovative Biologics and Biosimilars & Forecasts, 2018-2029
7.3.2 By Country, North America Innovative Biologics and Biosimilars Market Size Market Share7.4 Europe
7.4.1 Europe Innovative Biologics and Biosimilars Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Innovative Biologics and Biosimilars Market Size Market Share7.5 Asia Pacific
7.5.1 Asia Pacific Innovative Biologics and Biosimilars Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Innovative Biologics and Biosimilars Market Size Market Share7.6 South America
7.6.1 South America Innovative Biologics and Biosimilars Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Innovative Biologics and Biosimilars Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level8.1 By Country, Global Innovative Biologics and Biosimilars Market Size & CAGR, 2018 VS 2022 VS 2029
8.2 By Country, Global Innovative Biologics and Biosimilars Consumption Value, 2018-2029
8.3 U.S.
8.3.1 U.S. Innovative Biologics and Biosimilars Market Size, 2018-2029
8.3.2 By Type, U.S. Innovative Biologics and Biosimilars Consumption Value Market Share, 2022 VS 2029
8.3.3 By Application, U.S. Innovative Biologics and Biosimilars Consumption Value Market Share, 2022 VS 20298.4 Europe
8.4.1 Europe Innovative Biologics and Biosimilars Market Size, 2018-2029
8.4.2 By Type, Europe Innovative Biologics and Biosimilars Consumption Value Market Share, 2022 VS 2029
8.4.3 By Application, Europe Innovative Biologics and Biosimilars Consumption Value Market Share, 2022 VS 20298.5 China
8.5.1 China Innovative Biologics and Biosimilars Market Size, 2018-2029
8.5.2 By Type, China Innovative Biologics and Biosimilars Consumption Value Market Share, 2022 VS 2029
8.5.3 By Application, China Innovative Biologics and Biosimilars Consumption Value Market Share, 2022 VS 20298.6 Japan
8.6.1 Japan Innovative Biologics and Biosimilars Market Size, 2018-2029
8.6.2 By Type, Japan Innovative Biologics and Biosimilars Consumption Value Market Share, 2022 VS 2029
8.6.3 By Application, Japan Innovative Biologics and Biosimilars Consumption Value Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Innovative Biologics and Biosimilars Market Size, 2018-2029
8.7.2 By Type, South Korea Innovative Biologics and Biosimilars Consumption Value Market Share, 2022 VS 2029
8.7.3 By Application, South Korea Innovative Biologics and Biosimilars Consumption Value Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Innovative Biologics and Biosimilars Market Size, 2018-2029
8.8.2 By Type, Southeast Asia Innovative Biologics and Biosimilars Consumption Value Market Share, 2022 VS 2029
8.8.3 By Application, Southeast Asia Innovative Biologics and Biosimilars Consumption Value Market Share, 2022 VS 2029
8.9 India
8.9.1 India Innovative Biologics and Biosimilars Market Size, 2018-2029
8.9.2 By Type, India Innovative Biologics and Biosimilars Consumption Value Market Share, 2022 VS 2029
8.9.3 By Application, India Innovative Biologics and Biosimilars Consumption Value Market Share, 2022 VS 20298.10 Middle East & Africa
8.10.1 Middle East & Africa Innovative Biologics and Biosimilars Market Size, 2018-2029
8.10.2 By Type, Middle East & Africa Innovative Biologics and Biosimilars Consumption Value Market Share, 2022 VS 2029
8.10.3 By Application, Middle East & Africa Innovative Biologics and Biosimilars Consumption Value Market Share, 2022 VS 2029
9 Company Profile9.1 Roche
9.1.1 Roche Company Information, Head Office, Market Area and Industry Position
9.1.2 Roche Company Profile and Main Business
9.1.3 Roche Innovative Biologics and Biosimilars Models, Specifications and Application
9.1.4 Roche Innovative Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.1.5 Roche Recent Developments9.2 Amgen
9.2.1 Amgen Company Information, Head Office, Market Area and Industry Position
9.2.2 Amgen Company Profile and Main Business
9.2.3 Amgen Innovative Biologics and Biosimilars Models, Specifications and Application
9.2.4 Amgen Innovative Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.2.5 Amgen Recent Developments9.3 AbbVie
9.3.1 AbbVie Company Information, Head Office, Market Area and Industry Position
9.3.2 AbbVie Company Profile and Main Business
9.3.3 AbbVie Innovative Biologics and Biosimilars Models, Specifications and Application
9.3.4 AbbVie Innovative Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.3.5 AbbVie Recent Developments9.4 Sanofi
9.4.1 Sanofi Company Information, Head Office, Market Area and Industry Position
9.4.2 Sanofi Company Profile and Main Business
9.4.3 Sanofi Innovative Biologics and Biosimilars Models, Specifications and Application
9.4.4 Sanofi Innovative Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.4.5 Sanofi Recent Developments9.5 Johnson & Johnson
9.5.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
9.5.2 Johnson & Johnson Company Profile and Main Business
9.5.3 Johnson & Johnson Innovative Biologics and Biosimilars Models, Specifications and Application
9.5.4 Johnson & Johnson Innovative Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.5.5 Johnson & Johnson Recent Developments9.6 Pfizer
9.6.1 Pfizer Company Information, Head Office, Market Area and Industry Position
9.6.2 Pfizer Company Profile and Main Business
9.6.3 Pfizer Innovative Biologics and Biosimilars Models, Specifications and Application
9.6.4 Pfizer Innovative Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.6.5 Pfizer Recent Developments
9.7 Novo Nordisk
9.7.1 Novo Nordisk Company Information, Head Office, Market Area and Industry Position
9.7.2 Novo Nordisk Company Profile and Main Business
9.7.3 Novo Nordisk Innovative Biologics and Biosimilars Models, Specifications and Application
9.7.4 Novo Nordisk Innovative Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.7.5 Novo Nordisk Recent Developments
9.8 Eli Lilly
9.8.1 Eli Lilly Company Information, Head Office, Market Area and Industry Position
9.8.2 Eli Lilly Company Profile and Main Business
9.8.3 Eli Lilly Innovative Biologics and Biosimilars Models, Specifications and Application
9.8.4 Eli Lilly Innovative Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.8.5 Eli Lilly Recent Developments
9.9 Novartis
9.9.1 Novartis Company Information, Head Office, Market Area and Industry Position
9.9.2 Novartis Company Profile and Main Business
9.9.3 Novartis Innovative Biologics and Biosimilars Models, Specifications and Application
9.9.4 Novartis Innovative Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.9.5 Novartis Recent Developments9.10 Merck
9.10.1 Merck Company Information, Head Office, Market Area and Industry Position
9.10.2 Merck Company Profile and Main Business
9.10.3 Merck Innovative Biologics and Biosimilars Models, Specifications and Application
9.10.4 Merck Innovative Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.10.5 Merck Recent Developments
9.11 Biogen
9.11.1 Biogen Company Information, Head Office, Market Area and Industry Position
9.11.2 Biogen Company Profile and Main Business
9.11.3 Biogen Innovative Biologics and Biosimilars Models, Specifications and Application
9.11.4 Biogen Innovative Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.11.5 Biogen Recent Developments
9.12 Celltrion
9.12.1 Celltrion Company Information, Head Office, Market Area and Industry Position
9.12.2 Celltrion Company Profile and Main Business
9.12.3 Celltrion Innovative Biologics and Biosimilars Models, Specifications and Application
9.12.4 Celltrion Innovative Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.12.5 Celltrion Recent Developments
9.13 Sobi
9.13.1 Sobi Company Information, Head Office, Market Area and Industry Position
9.13.2 Sobi Company Profile and Main Business
9.13.3 Sobi Innovative Biologics and Biosimilars Models, Specifications and Application
9.13.4 Sobi Innovative Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.13.5 Sobi Recent Developments
9.14 3SBIO
9.14.1 3SBIO Company Information, Head Office, Market Area and Industry Position
9.14.2 3SBIO Company Profile and Main Business
9.14.3 3SBIO Innovative Biologics and Biosimilars Models, Specifications and Application
9.14.4 3SBIO Innovative Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.14.5 3SBIO Recent Developments
9.15 Changchun High Tech
9.15.1 Changchun High Tech Company Information, Head Office, Market Area and Industry Position
9.15.2 Changchun High Tech Company Profile and Main Business
9.15.3 Changchun High Tech Innovative Biologics and Biosimilars Models, Specifications and Application
9.15.4 Changchun High Tech Innovative Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.15.5 Changchun High Tech Recent Developments
9.16 Kanghong Pharma
9.16.1 Kanghong Pharma Company Information, Head Office, Market Area and Industry Position
9.16.2 Kanghong Pharma Company Profile and Main Business
9.16.3 Kanghong Pharma Innovative Biologics and Biosimilars Models, Specifications and Application
9.16.4 Kanghong Pharma Innovative Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.16.5 Kanghong Pharma Recent Developments
9.17 Innovent Biologics
9.17.1 Innovent Biologics Company Information, Head Office, Market Area and Industry Position
9.17.2 Innovent Biologics Company Profile and Main Business
9.17.3 Innovent Biologics Innovative Biologics and Biosimilars Models, Specifications and Application
9.17.4 Innovent Biologics Innovative Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.17.5 Innovent Biologics Recent Developments
9.18 Gan&Lee
9.18.1 Gan&Lee Company Information, Head Office, Market Area and Industry Position
9.18.2 Gan&Lee Company Profile and Main Business
9.18.3 Gan&Lee Innovative Biologics and Biosimilars Models, Specifications and Application
9.18.4 Gan&Lee Innovative Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.18.5 Gan&Lee Recent Developments
9.19 Tonghua Dongbao
9.19.1 Tonghua Dongbao Company Information, Head Office, Market Area and Industry Position
9.19.2 Tonghua Dongbao Company Profile and Main Business
9.19.3 Tonghua Dongbao Innovative Biologics and Biosimilars Models, Specifications and Application
9.19.4 Tonghua Dongbao Innovative Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.19.5 Tonghua Dongbao Recent Developments9.20 United Laboratory
9.20.1 United Laboratory Company Information, Head Office, Market Area and Industry Position
9.20.2 United Laboratory Company Profile and Main Business
9.20.3 United Laboratory Innovative Biologics and Biosimilars Models, Specifications and Application
9.20.4 United Laboratory Innovative Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.20.5 United Laboratory Recent Developments
10 Conclusion
11 Appendix11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources11.3 Market Estimation Model
11.4 Disclaimer
-
The Innovative Biologics and Biosimilars Global and China Top Players Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Recognize the areas along the Innovative Biologics and Biosimilars Global and China Top Players Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
Innovative Biologics and Biosimilars Global and China Top Players has a wide range of applications, including
The Innovative Biologics and Biosimilars Global and China Top Players Market is expected to grow at a moderate CAGR during the forecast period of 2024 to 2029.
The convergence of various vital triggers, including a major slowdown in Western economies, and some critical points in globalization, leads to the transformation of business in the Innovative Biologics and Biosimilars Global and China Top Players Market across the extensive corporate landscape.
This latest research publication on the Innovative Biologics and Biosimilars Global and China Top Players Market is an in-depth market tracker that provides a comprehensive assessment of the challenges that manufacturers face in achieving new growth cycles in the current scenario.
